Long Term outcomes of percutaneous atrial fibrillation ablation in patients with continuous monitoring
| Autor: | Jonathan Hyde, Nick Freemantle, Steven J. Podd, Conn Sugihara, William Eysenck, Rick A. Veasey, Michael Lewis, Stephen Furniss, Neil Sulke, Rajdip Dulai |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
medicine.medical_specialty Time Factors Percutaneous medicine.medical_treatment 030204 cardiovascular system & hematology Pulmonary vein Cohort Studies 03 medical and health sciences 0302 clinical medicine Interquartile range Internal medicine Atrial Fibrillation medicine Humans In patient 030212 general & internal medicine Aged business.industry Atrial fibrillation Cryoablation General Medicine Middle Aged medicine.disease Ablation Treatment Outcome Relative risk Catheter Ablation Cardiology Female Cardiology and Cardiovascular Medicine business |
| Zdroj: | Pacing and Clinical Electrophysiology. 44:1176-1184 |
| ISSN: | 1540-8159 0147-8389 |
| Popis: | INTRODUCTION There is limited data using continuous monitoring to assess outcomes of atrial fibrillation (AF) ablation. This study assessed long-term outcomes of AF ablation in patients with implantable cardiac devices. METHODS 207 patients (mean age 68.1 ± 9.5, 50.3% men) undergoing ablation for symptomatic AF were followed up for a mean period of 924.5 ± 636.7 days. Techniques included The Pulmonary Vein Ablation Catheter (PVAC) (59.4%), cryoablation (17.4%), point by point (14.0%) and The Novel Irrigated Multipolar Radiofrequency Ablation Catheter (nMARQ) (9.2%). RESULTS 130 (62.8%) patients had paroxysmal AF (PAF) and 77 (37.2%) persistent AF. First ablation and repeat ablation reduced AF burden significantly (relative risk 0.91, [95% CI 0.89 to 0.94]; P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|